Clinical Trials for Refractory Rheumatoid Arthritis (RA)

Find clinical trials for refractory rheumatoid arthritis (ra). Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT ID: NCT06991114

This clinical trial is studying a new treatment called AlloNK, which uses natural killer (NK) cells derived from umbilical cord blood, combined with a medication called rituximab. The trial is aime...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tucson, Arizona, United States, Aventura, Florida, United States +5 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions